Jupiter Endovascular
About Jupiter Endovascular
Develops the Vertex Pulmonary Embolectomy System, which uses Endoportal Control™ technology to combine surgical precision with catheter-based interventions for treating pulmonary embolism. This system addresses the limitations of current thrombus removal methods by enabling safer, more controlled procedures that improve patient outcomes in cardiovascular care.
```xml <problem> Current methods for removing thrombi in patients with pulmonary embolism (PE) have limitations in safety and control, potentially leading to incomplete removal and adverse outcomes. Existing catheter-based interventions may lack the precision of surgical techniques, while traditional surgery carries significant risks. </problem> <solution> Jupiter Endovascular is developing the Vertex Pulmonary Embolectomy System, which combines the precision of surgical techniques with the safety and simplicity of catheter-based interventions using their proprietary Endoportal Control™ technology. This system aims to improve the treatment of pulmonary embolism by enabling safer, more controlled procedures for thrombus removal. The Vertex system is designed to navigate the pulmonary vasculature, precisely target and remove clots, and minimize the risk of complications associated with traditional methods. By integrating surgical precision with endovascular access, the system offers a novel approach to PE treatment, potentially leading to improved patient outcomes and reduced recovery times. The company's focus is on reimagining therapies for cardiovascular diseases, with pulmonary embolism as its initial target. </solution> <features> - Endoportal Control™ technology for enhanced surgical precision during catheter-based interventions. - Minimally invasive approach to reduce patient trauma and recovery time. - Precise targeting and controlled removal of thrombi within the pulmonary vasculature. - Designed to address the limitations of existing thrombus removal methods. </features> <target_audience> The primary target audience includes interventional cardiologists, vascular surgeons, and other medical professionals specializing in the treatment of pulmonary embolism and cardiovascular diseases. </target_audience> ```
What does Jupiter Endovascular do?
Develops the Vertex Pulmonary Embolectomy System, which uses Endoportal Control™ technology to combine surgical precision with catheter-based interventions for treating pulmonary embolism. This system addresses the limitations of current thrombus removal methods by enabling safer, more controlled procedures that improve patient outcomes in cardiovascular care.
Where is Jupiter Endovascular located?
Jupiter Endovascular is based in Menlo Park, United States.
When was Jupiter Endovascular founded?
Jupiter Endovascular was founded in 2024.
How much funding has Jupiter Endovascular raised?
Jupiter Endovascular has raised 21000000.
Who founded Jupiter Endovascular?
Jupiter Endovascular was founded by Alex Tilson.
- Alex Tilson - CEO
- Location
- Menlo Park, United States
- Founded
- 2024
- Funding
- 21000000
- Employees
- 38 employees
- Major Investors
- Sonder Capital